Search Results - "SMIT, Frank P"
-
1
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
Published in European urology (01-11-2016)“…Abstract Background To reduce overdiagnosis and overtreatment, a test is urgently needed to detect clinically significant prostate cancer (PCa). Objective To…”
Get full text
Journal Article -
2
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
Published in Clinical cancer research (01-07-2015)“…Serum PSA (sPSA) testing has led to the identification of patients with indolent prostate cancer, and inevitably overtreatment has become a concern. Progensa…”
Get full text
Journal Article -
3
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Published in European urology (01-03-2014)“…Abstract Background Prostate cancer antigen 3 ( PCA3 ) and v-ets erythroblastosis virus E26 oncogene homolog ( TMPRSS2-ERG ) gene fusions are promising…”
Get full text
Journal Article -
4
Prostate cancer biomarker profiles in urinary sediments and exosomes
Published in The Journal of urology (01-04-2014)“…Urinary biomarker tests for diagnosing prostate cancer have gained considerable interest. Urine is a complex mixture that can be subfractionated. We evaluated…”
Get more information
Journal Article -
5
Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate Cancer
Published in Clinical cancer research (01-09-2007)“…Purpose: Early detection of prostate cancer can increase the curative success rate for prostate cancer. We studied the diagnostic usefulness of TMPRSS2-ERG…”
Get full text
Journal Article -
6
Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients
Published in The Prostate (01-04-2018)“…Background : Noninvasive biomarkers to guide personalized treatment for castration‐resistant prostate cancer (CRPC) are needed. In this study, we analyzed…”
Get full text
Journal Article -
7
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder
Published in Molecular oncology (01-07-2021)“…Bladder urothelial cell carcinoma (UCC) incidence is about three times higher in men compared with women. There are several indications for the involvement of…”
Get full text
Journal Article -
8
The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer
Published in Non-coding RNA (01-12-2022)“…Castration resistance is the leading cause of death in men with prostate cancer. Recent studies indicate long noncoding RNAs (lncRNAs) to be important drivers…”
Get full text
Journal Article -
9
Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in dutch prostate cancer patients
Published in The Prostate (01-03-2011)“…BACKGROUND The occurrence of the retrovirus xenotropic murine leukemia virus (MLV)‐related virus (XMRV) has been reported in prostate tissue of patients with…”
Get full text
Journal Article -
10
Steroidogenic Enzymes and Stem Cell Markers Are Upregulated during Androgen Deprivation in Prostate Cancer
Published in Molecular medicine (Cambridge, Mass.) (01-07-2011)Get full text
Journal Article -
11
Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics
Published in International journal of molecular sciences (06-11-2024)“…Microarray and Single-Molecule Molecular Inversion Probe (smMIP)-based targeted RNA sequencing are two RNA profiling platforms for identifying…”
Get full text
Journal Article -
12
miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2
Published in Cancer research (Chicago, Ill.) (15-04-2017)“…Reversing epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic…”
Get full text
Journal Article -
13
Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer
Published in Molecular medicine (Cambridge, Mass.) (01-01-2011)“…Considerable levels of testosterone and dihydrotestosterone (DHT) are found in prostate cancer (PCa) tissue after androgen deprivation therapy. Treatment of…”
Get full text
Journal Article -
14
High‐resolution ERG‐expression profiling on GeneChip exon 1.0 ST arrays in primary and castration‐resistant prostate cancer
Published in BJU international (01-05-2013)“…Objective To assess whether oestrogen‐regulated gene (ERG) expression analysis using GeneChip arrays can predict transmembrane protease, serine 2 (TMPRSS2)‐ERG…”
Get full text
Journal Article -
15
Dutasteride and Enzalutamide Synergistically Suppress Prostate Tumor Cell Proliferation
Published in The Journal of urology (01-03-2015)“…Purpose Dihydrotestosterone is the main active androgen in the prostate and it has a role in prostate cancer progression. After androgen deprivation therapy…”
Get full text
Journal Article -
16
DD3 : A new prostate-specific gene, highly overexpressed in prostate cancer
Published in Cancer research (Chicago, Ill.) (01-12-1999)“…Prostate cancer is the most commonly diagnosed malignancy and the second leading cause of cancer-related deaths in the Western male population. Despite the…”
Get full text
Journal Article -
17
Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer
Published in The Prostate (01-01-2010)“…BACKGROUND PCA3 is one of the most prostate cancer (PrCa)‐specific markers described so far. Recently, a new genomic structure of PCA3 as well as new flanking…”
Get full text
Journal Article -
18
Broadband Diversity Antenna Array for UHF Digital TV
Published in 2022 International Symposium on Antennas and Propagation (ISAP) (31-10-2022)“…This article describes the design and test of a UHF broadband array antenna for applications in Digital Terrestrial TV Broadcasting (DTTB) TV 3.0 project…”
Get full text
Conference Proceeding -
19
The Androgen Regulated lncRNA INAALADL2-AS2/I Promotes Tumor Cell Survival in Prostate Cancer
Published in Non-coding RNA (01-12-2022)“…Castration resistance is the leading cause of death in men with prostate cancer. Recent studies indicate long noncoding RNAs (lncRNAs) to be important drivers…”
Get full text
Journal Article -
20
High‐resolution ERG ‐expression profiling on G eneChip exon 1.0 ST arrays in primary and castration‐resistant prostate cancer
Published in BJU international (01-05-2013)Get full text
Journal Article